HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Victor F Mautner Selected Research

Neurofibromatosis 1 (Neurofibromatosis Type I)

10/2022Evaluation of magnetic resonance imaging-based radiomics characteristics for differentiation of benign and malignant peripheral nerve sheath tumors in neurofibromatosis type 1.
7/2018Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts.
8/2016Current whole-body MRI applications in the neurofibromatoses: NF1, NF2, and schwannomatosis.
8/2016Recurrent multilocular mandibular giant cell granuloma in neurofibromatosis type 1: Evidence for second hit mutation of NF1 gene in the jaw lesion and treatment with curettage and bone substitute materials.
8/2015Perfusion single photon emission computed tomography in a mouse model of neurofibromatosis type 1: towards a biomarker of neurologic deficits.
1/2015Double NF1 inactivation affects adrenocortical function in NF1Prx1 mice and a human patient.
5/2014Differences of 25-hydroxyvitamin D3 concentrations in children and adults with neurofibromatosis type 1.
2/201418F-FDG PET/CT for detection of malignant peripheral nerve sheath tumours in neurofibromatosis type 1: tumour-to-liver ratio is superior to an SUVmax cut-off.
4/2013Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors.
1/2013Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Victor F Mautner Research Topics

Disease

16Neoplasms (Cancer)
10/2022 - 05/2004
14Neurofibromatosis 1 (Neurofibromatosis Type I)
10/2022 - 05/2004
10Neurofibrosarcoma (MPNST)
10/2022 - 05/2004
4Plexiform Neurofibroma
04/2015 - 11/2005
3Nerve Sheath Neoplasms (Nerve Sheath Neoplasm)
10/2022 - 07/2004
3Neurofibromatoses (Neurofibromatosis)
08/2016 - 01/2012
3Neurofibroma
05/2014 - 10/2010
2Neurofibromatosis 2 (Neurofibromatosis Type II)
08/2016 - 01/2002
1Disease Progression
01/2017
1Schwannomatosis
08/2016
1Anodontia (Hypodontia)
08/2016
1Giant Cell Granuloma (Peripheral Giant Cell Granuloma)
08/2016
1Thyroiditis
08/2016
1Neurologic Manifestations (Neurological Manifestations)
08/2015
1Communicable Diseases (Infectious Diseases)
04/2015
1Hyperplasia
01/2015
1Adenoma (Adenomas)
01/2015
1Leukemia
01/2014
1Body Weight (Weight, Body)
01/2014
1Acoustic Neuroma (Acoustic Neurinoma)
05/2013
1Carcinogenesis
11/2005
1Neurilemmoma (Schwannoma)
07/2004

Drug/Important Bio-Agent (IBA)

5Biomarkers (Surrogate Marker)IBA
08/2015 - 10/2010
2Biological ProductsIBA
10/2022 - 07/2009
2Tretinoin (Retinoic Acid)FDA LinkGeneric
07/2018 - 07/2017
2ParaffinIBA
07/2017 - 02/2012
2Pharmaceutical PreparationsIBA
01/2017 - 04/2015
2nilotinibFDA Link
04/2015 - 01/2014
2Imatinib Mesylate (Gleevec)FDA Link
04/2015 - 01/2014
2DNA (Deoxyribonucleic Acid)IBA
01/2015 - 01/2002
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
02/2014 - 01/2013
1Atrial Natriuretic Factor (ANF)IBA
10/2022
1Estrogens (Estrogen)FDA Link
01/2020
1ProgesteroneFDA LinkGeneric
01/2020
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
07/2018
1mirdametinibIBA
07/2018
1Therapeutic UsesIBA
07/2018
1InterferonsIBA
07/2017
1Formaldehyde (Formol)FDA Link
07/2017
1Carrier Proteins (Binding Protein)IBA
07/2017
1Uvitex SWN (SWN)IBA
08/2016
1Bone SubstitutesIBA
08/2016
1AntibodiesIBA
04/2015
1Anti-Bacterial Agents (Antibiotics)IBA
04/2015
1Adrenocorticotropic Hormone (ACTH)FDA Link
01/2015
1Neurofibromin 1 (Neurofibromin)IBA
01/2015
1Hydrocortisone (Cortisol)FDA LinkGeneric
01/2015
1Cholecalciferol (Vitamin D3)FDA Link
05/2014
1Calcifediol (Calcidiol)FDA Link
05/2014
1Phosphotransferases (Kinase)IBA
01/2014
1Tyrosine Kinase InhibitorsIBA
01/2014
1Insulin-Like Growth Factor Binding Protein 1IBA
04/2013
1Chemokine CCL5IBA
04/2013
1CytokinesIBA
04/2013
1Aurora KinasesIBA
01/2013
1MLN 8237IBA
01/2013
1Aurora Kinase AIBA
01/2013
1Monoclonal AntibodiesIBA
02/2012
1Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA
02/2012
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
10/2010
1Proteins (Proteins, Gene)FDA Link
10/2010
1AdrenomedullinIBA
10/2010
1Conditioned Culture MediaIBA
10/2010
1ras GTPase-Activating Proteins (ras-GAP)IBA
07/2007
1MidkineIBA
11/2005
1Heparin (Liquaemin)FDA LinkGeneric
11/2005
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2005
1Melanins (Melanin)IBA
07/2004
1Sulindac (Copal)FDA LinkGeneric
05/2004
1sulindac sulfone (exisulind)IBA
05/2004
1sulindac sulfideIBA
05/2004
1Guanosine Triphosphate (GTP)IBA
05/2004
1ProdrugsIBA
05/2004
1Antineoplastic Agents (Antineoplastics)IBA
05/2004

Therapy/Procedure

6Therapeutics
08/2016 - 07/2012
2Drug Therapy (Chemotherapy)
07/2018 - 01/2013
1Curettage
08/2016
1Radiotherapy
11/2005